Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies

NCT00251407 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Taxotere
DRUG: Cisplatin
DRUG: CPT-11

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]